Evidence map›Paper›PMID 8676071›Full record

ArticleThe Journal of experimental medicine1996

Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects.

F di Marzo Veronese, D Arnott, V Barnaba, D J Loftus, K Sakaguchi, C B Thompson, S Salemi, C Mastroianni, A Sette, J Shabanowitz and 2 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular mimicry and T cell-mediated autoimmune disease.The Journal of experimental medicine · 1997
    Review
  11. Virus-induced autoimmune disease.Current opinion in immunology · 1996
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

F di Marzo VeroneseLaboratory of Tumor Cell Biology, National Institutes of Health, Bethesda, Maryland 20892, USA.
D Arnott
V Barnaba
D J Loftus
K Sakaguchi
C B Thompson
S Salemi
C Mastroianni
A Sette
J Shabanowitz
D F Hunt
E Appella
National Institutes of Health · US

Funding

PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRYR37AI033993 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUNT, DONALD F · 1999 to 2008
$5.6M
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRYR01AI033993 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUNT, DONALD F · 1994 to 2017
$4.9M
NIAID NIH HHS AI-33993
6 · The paper itself

Abstract

A subtractive analysis of peptides eluted from major histocompatibility complex (MHC) class I human histocompatibility leukocyte antigen (HLA)-A2.1 molecules purified from either human immunodeficiency virus type-1 (HIV-1)-infected or uninfected cells was performed using micro high-performance liquid chromatography and mass spectrometry. Three peptides unique to infected cells were identified and found to derive from a single protein, human vinculin, a structural protein not known to be involved in viral pathogenesis. Molecular and cytofluorometric analyses revealed vinculin mRNA and vinculin protein overexpression in B and T lymphocytes from HIV-1-infected individuals. Vinculin peptide-specific CTL activity was readily elicited from peripheral blood lymphocytes of the majority of HLA-A2.1+, HIV+ patients tested. Our observations suggest that atypical vinculin expression and MHC class I-mediated presentation of vinculin-derived peptides accompany HIV infection of lymphoid cells in vivo, with a resultant induction of antivinculin CTL in a significant portion of HIV+ (HLA-A2.1+) individuals.

Indexed as

Amino Acid SequenceBinding SitesB-LymphocytesChromatography, High Pressure LiquidCytotoxicity, ImmunologicFlow CytometryHIV-1HIV InfectionsHLA-A2 AntigenHumansMajor Histocompatibility ComplexMass SpectrometryMolecular Sequence DataPeptidesReference ValuesT-LymphocytesHLA-A2 AntigenPeptidesVinculinViral Proteins

Identifiers

PMID8676071
PMCPMC2192610
OpenAlexW2165050288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.